Quanterix/QTRX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Quanterix

Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.

Ticker

QTRX

Sector

Healthcare

Trading on

NASDAQ

Industry

Scientific & Technical Instr.

CEO

Masoud Toloue

Employees

441

Headquarters

Billerica, United States

Quanterix Metrics

BasicAdvanced
$611M
Market cap
-
P/E ratio
-$0.96
EPS
1.51
Beta
-
Dividend rate
$611M
1.50621
$29.70
$14.26
378K
11.376
10.569
-8.65%
-10.39%
-9.31%
4.851
1.794
1.818
20.64%
58.02%
12.31%

What the Analysts think about Quanterix

Analyst Ratings

Majority rating from 5 analysts.
Buy

Quanterix Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-31.25% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$32M
1.59%
Net income
-$10M
-19.35%
Profit margin
-31.25%
-20.60%

Quanterix Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 17.46%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.16
-$0.21
-$0.33
-$0.26
-
Expected
-$0.38
-$0.37
-$0.32
-$0.32
-$0.25
Surprise
-57.62%
-43.24%
3.77%
-17.46%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Quanterix stock?

Quanterix (QTRX) has a market cap of $611M as of June 17, 2024.

What is the P/E ratio for Quanterix stock?

The price to earnings (P/E) ratio for Quanterix (QTRX) stock is 0 as of June 17, 2024.

Does Quanterix stock pay dividends?

No, Quanterix (QTRX) stock does not pay dividends to its shareholders as of June 17, 2024.

When is the next Quanterix dividend payment date?

Quanterix (QTRX) stock does not pay dividends to its shareholders.

What is the beta indicator for Quanterix?

Quanterix (QTRX) has a beta rating of 1.51. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Quanterix stock price target?

The target price for Quanterix (QTRX) stock is $25.33, which is NaN% below the current price of $. This is an average based on projections from 6 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Quanterix stock

Buy or sell Quanterix stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing